Life Sciences
Home >> Views >> Life Sciences
Fudan-Zhangjiang (HKG:8231) Sees 2011 Net Profit Up Sharply
Source£ºCCMR   Data£º2016-1-5

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:8231) expected to record a substantial increase in profits for the year ended 31 December 2011 as compared to the profits in the year 2010. Such increase in profits is mainly attributable to the Strategic Cooperation Agreement for innovative pharmaceuticals research and development entered into between the Company and Shanghai Pharmaceuticals, pursuant to which Shanghai Pharmaceutical shared part of the research expenses of some of the Group¡¯s project).

Related Hot
Copyright © 2012-2020  CCMR | China Ceidea Market Research Co., LTD  Inc. All rights reserved.
Add£ºRoom 406 Huide Building No 102 Hao Xian Road Yuexiu District Guangzhou Tel£º+86-020-28931413 +86 13503051005